compound introduction
TGFβRI-IN-3 inhibits TGFβR1 at an IC 50 of 0.79 nM with 2000-fold selectivity against MAP4K4. TGFβRI-IN-3 represents a highly selective TGFβR1 inhibitor that has potential applications in immuno-oncology. Appearance:Solid IC50& Target:IC50: 0.79 nM (TGFβR1) In Vitro:TGFβRI-IN-3 inhibits TGFβR1 at an IC 50 of 0.79 nM with 2000-fold selectivity against MAP4K4. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Biological Activity:TGFβRI-IN-3 inhibits TGFβR1 at an IC 50 of 0.79 nM with 2000-fold selectivity against MAP4K4. TGFβRI-IN-3 represents a highly selective TGFβR1 inhibitor that has potential applications in immuno-oncology.
